The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The study was done to determine whether eptifibatide, a platelet glycoprotein (GP) IIb/IIIa antagonist, prevents ischemic complications following percutaneous coronary interventions (PCIs) in women as well as in men.Eptifibatide reduces ischemic complications after nonurgent coronary stent interventions.We compared outcomes in women (n = 562) and men (n = 1,502) enrolled in the Enhanced Suppression...
To assess the potential benefit of GP IIb/IIIa inhibitors with coronary stenting, we studied 160 patients who required stents for true/threatened closure in the IMPACT II trial. In this trial of 4010 patients, no stents were placed electively by protocol design. A composite end point of death, MI, urgent repeate intervention or CABG was compared between the stent patients in the placebo arm vs....
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.